Tariq E. Farrah

1.1k total citations
29 papers, 643 citations indexed

About

Tariq E. Farrah is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Tariq E. Farrah has authored 29 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 8 papers in Nephrology. Recurrent topics in Tariq E. Farrah's work include Vasculitis and related conditions (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Renal and Vascular Pathologies (5 papers). Tariq E. Farrah is often cited by papers focused on Vasculitis and related conditions (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Renal and Vascular Pathologies (5 papers). Tariq E. Farrah collaborates with scholars based in United Kingdom, United States and France. Tariq E. Farrah's co-authors include Neeraj Dhaun, David J. Webb, Peter J. Gallacher, Nikolaos Tzoumas, Baljean Dhillon, Pearse A. Keane, Robert W. Hunter, James W. Dear, David Kluth and Eve Miller‐Hodges and has published in prestigious journals such as Circulation, Nature Communications and The FASEB Journal.

In The Last Decade

Tariq E. Farrah

28 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tariq E. Farrah United Kingdom 16 179 155 128 102 101 29 643
Nilüfer Bayraktar Türkiye 16 130 0.7× 104 0.7× 62 0.5× 85 0.8× 192 1.9× 70 857
Taner Ulus Türkiye 17 85 0.5× 337 2.2× 93 0.7× 138 1.4× 122 1.2× 57 715
Nicola Joss United Kingdom 12 72 0.4× 105 0.7× 82 0.6× 160 1.6× 166 1.6× 25 945
M A Bettmann United States 11 273 1.5× 140 0.9× 113 0.9× 104 1.0× 33 0.3× 23 740
Özgür Günebakmaz Türkiye 17 222 1.2× 689 4.4× 136 1.1× 142 1.4× 76 0.8× 54 1.2k
Dimitrios A. Vrachatis Greece 17 226 1.3× 784 5.1× 113 0.9× 60 0.6× 236 2.3× 100 1.3k
Yumi Miyashita Japan 22 416 2.3× 132 0.9× 142 1.1× 23 0.2× 136 1.3× 48 1.2k
Murat Turfan Türkiye 16 95 0.5× 406 2.6× 120 0.9× 51 0.5× 68 0.7× 54 754
Osman Bolca Türkiye 18 160 0.9× 478 3.1× 148 1.2× 33 0.3× 34 0.3× 62 815
Yusuf Tavıl Türkiye 20 156 0.9× 603 3.9× 130 1.0× 141 1.4× 127 1.3× 70 1.1k

Countries citing papers authored by Tariq E. Farrah

Since Specialization
Citations

This map shows the geographic impact of Tariq E. Farrah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tariq E. Farrah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tariq E. Farrah more than expected).

Fields of papers citing papers by Tariq E. Farrah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tariq E. Farrah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tariq E. Farrah. The network helps show where Tariq E. Farrah may publish in the future.

Co-authorship network of co-authors of Tariq E. Farrah

This figure shows the co-authorship network connecting the top 25 collaborators of Tariq E. Farrah. A scholar is included among the top collaborators of Tariq E. Farrah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tariq E. Farrah. Tariq E. Farrah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salehi, Tania, Gavin Chapman, Tariq E. Farrah, et al.. (2025). Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis. Kidney International Reports. 10(7). 2334–2343.
2.
Farrah, Tariq E., Dan Pugh, Fiona A. Chapman, et al.. (2023). Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment. Nature Communications. 14(1). 7720–7720. 16 indexed citations
3.
Pugh, Dan, Tariq E. Farrah, Tom MacGillivray, et al.. (2023). Evaluation of an Automated Choroid Segmentation Algorithm in a Longitudinal Kidney Donor and Recipient Cohort. Translational Vision Science & Technology. 12(11). 19–19. 3 indexed citations
4.
MacIntyre, I., Emma Turtle, Tariq E. Farrah, et al.. (2022). Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 145(6). 416–423. 30 indexed citations
5.
Giarratano, Ylenia, Dan Pugh, Tariq E. Farrah, et al.. (2022). Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors. Kidney International. 102(3). 661–665. 1 indexed citations
6.
Farrah, Tariq E., Vanessa Melville, Alicja Czopek, et al.. (2022). Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis. Kidney International. 102(5). 1115–1126. 15 indexed citations
7.
Czopek, Alicja, Peter J. Gallacher, Dan Pugh, et al.. (2022). Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice. Science Translational Medicine. 14(675). eabf5074–eabf5074. 18 indexed citations
8.
Farrah, Tariq E., Baljean Dhillon, Pearse A. Keane, David J. Webb, & Neeraj Dhaun. (2020). The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons. Kidney International. 98(2). 323–342. 99 indexed citations
9.
Vliegenthart, A. D. Bastiaan, Laura Rivoli, Wilna Oosthuyzen, et al.. (2020). Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease. iScience. 24(1). 101937–101937. 18 indexed citations
10.
Hunter, Robert W., et al.. (2020). ANCA associated vasculitis. BMJ. 369. m1070–m1070. 54 indexed citations
11.
Guyonnet, Léa, Alicja Czopek, Tariq E. Farrah, et al.. (2020). Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury. Kidney International. 98(5). 1193–1209. 10 indexed citations
12.
Gallacher, Peter J., Tariq E. Farrah, Anna F. Dominiczak, et al.. (2020). Resistant Hypertension in a Dialysis Patient. Hypertension. 76(2). 278–287. 1 indexed citations
13.
Farrah, Tariq E., David J. Webb, & Neeraj Dhaun. (2019). Retinal fingerprints for precision profiling of cardiovascular risk. Nature Reviews Cardiology. 16(7). 379–381. 15 indexed citations
14.
Farrah, Tariq E., Atul Anand, Peter J. Gallacher, et al.. (2019). Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. Hypertension. 74(2). 323–330. 13 indexed citations
15.
Farrah, Tariq E., Peter J. Gallacher, Eve Miller‐Hodges, et al.. (2019). Long-term outcomes in elderly patients with ANCA-associated vasculitis. Lara D. Veeken. 59(5). 1076–1083. 36 indexed citations
16.
Pugh, Dan, Tariq E. Farrah, Peter J. Gallacher, David Kluth, & Neeraj Dhaun. (2018). Cyclophosphamide-Induced Lung Injury. Kidney International Reports. 4(3). 484–486. 9 indexed citations
17.
Czopek, Alicja, Léa Guyonnet, Tariq E. Farrah, et al.. (2018). A novel role for myeloid endothelin-B receptors in hypertension. European Heart Journal. 40(9). 768–784. 30 indexed citations
18.
Miller‐Hodges, Eve, Atul Anand, Anoop Shah, et al.. (2017). High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome. Circulation. 137(5). 425–435. 69 indexed citations
19.
Rivoli, Laura, Francesca Di Mario, Giuseppe Coppolino, et al.. (2016). Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy. Current Drug Metabolism. 17(6). 550–558. 2 indexed citations
20.
Steiger, M., Tariq E. Farrah, Keith Rolles, Peter Harvey, & Andrew K. Burroughs. (1994). Cyclosporin associated headache.. Journal of Neurology Neurosurgery & Psychiatry. 57(10). 1258–1259. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nilüfer Bayraktar Breakdown of academic impact, for papers by Taner Ulus Breakdown of academic impact, for papers by Nicola Joss Breakdown of academic impact, for papers by M A Bettmann Breakdown of academic impact, for papers by Özgür Günebakmaz Breakdown of academic impact, for papers by Dimitrios A. Vrachatis Breakdown of academic impact, for papers by Yumi Miyashita Breakdown of academic impact, for papers by Murat Turfan Breakdown of academic impact, for papers by Osman Bolca Breakdown of academic impact, for papers by Yusuf Tavıl
Rankless by CCL
2026